Attività
Vendite per attività
SEK in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Genomic Allergen Rapid Detection
100,0
%
| 42 | 100,0 % | 50 | 100,0 % | +19,39% |
Vendite per regione
SEK in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Sweden
100,0
%
| 42 | 100,0 % | 50 | 100,0 % | +19,39% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Peter Nählstedt
CEO | Chief Executive Officer | 50 | 01/01/18 |
Marianne Olsson
DFI | Director of Finance/CFO | 63 | 01/11/16 |
Henrik Johansson
CTO | Chief Tech/Sci/R&D Officer | 42 | 01/01/14 |
Director/Board Member | 59 | 15/10/14 | |
Public Communications Contact | 56 | 01/01/18 | |
Helen Olsson
HRO | Human Resources Officer | 59 | 01/01/20 |
Corporate Officer/Principal | 51 | 01/01/17 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Founder | 76 | 18/08/10 | |
Director/Board Member | 59 | 15/10/14 | |
Paula Zeilon
BRD | Director/Board Member | 62 | 01/01/20 |
Director/Board Member | 65 | 01/01/20 | |
Peter Nählstedt
CEO | Chief Executive Officer | 50 | 01/01/18 |
Ian Kimber
BRD | Director/Board Member | 74 | 01/01/15 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 24 188 325 | 14 889 392 ( 61,56 %) | 0 | 61,56 % |
Coordinate società
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
-20,45% | 10,82 Mrd | |
+43,17% | 3,25 Mrd | |
-35,86% | 2,11 Mrd | |
-17,21% | 2,08 Mrd | |
-29,81% | 1,48 Mrd | |
+17,56% | 1,02 Mrd | |
-4,37% | 733 Mln | |
-37,00% | 391 Mln | |
-46,94% | 383 Mln |